Vesna Spiric-Tomic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Case Report: Severe ANCA-positive eosinophilic granulomatosis with polyangiitis presenting with Loeffler endocarditis and cryofibrinogenemia-associated digital gangrene successfully treated with rituximab.

Case Report: Severe ANCA-positive eosinophilic granulomatosis with polyangiitis presenting with Loeffler endocarditis and cryofibrinogenemia-associated digital gangrene successfully treated with rituximab.

Journal: Frontiers in immunology

Published: May 16, 2026

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Journal: Allergy

Published: January 22, 2026

Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts.

Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts.

Journal: Allergy

Published: January 15, 2026

Systemic Allergic Reactions to Subcutaneous Allergen Immunotherapy-A Single-Center Experience.

Systemic Allergic Reactions to Subcutaneous Allergen Immunotherapy-A Single-Center Experience.

Journal: Life (Basel, Switzerland)

Published: August 18, 2025

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

Journal: The Lancet. Respiratory medicine

Published: August 03, 2025

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Journal: Allergy

Published: August 02, 2025

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.

Journal: Allergy

Published: July 17, 2025

Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study.

Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study.

Journal: Journal of clinical medicine

Published: July 08, 2025

Tryptase: The Silent Witness of Past and Ongoing Systemic Events.

Tryptase: The Silent Witness of Past and Ongoing Systemic Events.

Journal: Medicina (Kaunas, Lithuania)

Published: June 28, 2024

Allergen immunotherapy adverse events in adults with respiratory allergies-data from ADER: An EAACI task force report.

Allergen immunotherapy adverse events in adults with respiratory allergies-data from ADER: An EAACI task force report.

Journal: Allergy

Published: April 19, 2024

Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024).

Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024).

Journal: The journal of allergy and clinical immunology. In practice

Published: April 16, 2024

Successful Desensitization to Sorafenib and Imatinib-A Report of Two Cases and a Literature Review.

Successful Desensitization to Sorafenib and Imatinib-A Report of Two Cases and a Literature Review.

Journal: Healthcare (Basel, Switzerland)

Published: December 26, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026